Jane Agwaro
About Jane Agwaro
Jane Agwaro is an Associate Bioengineer II at Bristol Myers Squibb, specializing in Cell Therapy Analytical Development. She holds a Master's degree in Chemical & Biomolecular Engineering from Georgia Institute of Technology and a Bachelor's degree in Chemical Engineering from Tuskegee University.
Title
Jane Agwaro is an Associate Bioengineer II specializing in Cell Therapy Analytical Development at Bristol Myers Squibb. Her work location is in Warren, New Jersey, United States.
Company
Currently, Jane Agwaro works at Bristol Myers Squibb, where she contributes to the development of cell therapy analytical methods. Her role focuses on optimizing and developing procedures in the field of cell therapies.
Education and Expertise
Jane Agwaro studied at Georgia Institute of Technology, earning a Master of Science in Chemical & Biomolecular Engineering in 2019. She also graduated Summa Cum Laude from Tuskegee University with a Bachelor of Science in Chemical Engineering and a GPA of 3.95/4.00 in 2017. Her high school education was completed at MOI GIRLS HIGH SCHOOL ELDORET-KENYA, where she earned her High School Diploma.
Background
Jane Agwaro has a comprehensive background in bioengineering and chemical engineering. She has held roles such as Research Assistant at Georgia Institute of Technology, Engineering Leadership Development Intern at Altria, and NSF REU Intern at University of Utah College of Science. She has extensive experience in cell culturing, microscopy techniques, and process design and optimization using tools like Aspen Plus and Minitab.
Experience with Analytical Methods and Techniques
Jane Agwaro has expertise in various analytical methods crucial to her current role. She is skilled in cryosectioning techniques and autostaining for histological analysis, as well as advanced microscopy techniques including Scanning Electron Microscopy (SEM) and Spinning Disk Confocal Microscopy. Her proficiency also extends to the optimization of equipment, especially in spray drying techniques.